Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Female sexual dysfunction.

Deborah J Lightner1

  • 1Department of Urology, Mayo Clinic, Rochester, MN 55905, USA. lightner.deborah@mayo.edu

Mayo Clinic Proceedings
|July 11, 2002
PubMed
Summary
This summary is machine-generated.

Female sexual dysfunction (FSD) stems from organic causes, not solely psychological ones. New diagnostic tools and treatments are improving clinical evaluation and management for women experiencing FSD.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AUA White Paper on the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Urology practice·2023
Same author

The Overactive Bladder and the AUA Guidelines: A Proposed Clinical Pathway for Evaluation and Effective Management in a Contemporary Urology Practice.

Urology practice·2023
Same author

AUA Quality Improvement Summit 2014: Conference Proceedings on Infectious Complications of Transrectal Prostate Needle Biopsy.

Urology practice·2023
Same author

Editorial Commentary.

Urology practice·2023
Same author

Best Practice Statement on Urologic Procedures and Antimicrobial Prophylaxis.

The Journal of urology·2019
Same author

Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019.

The Journal of urology·2019
Same journal

Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study.

Mayo Clinic proceedings·2026
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
See all related articles

Area of Science:

  • Reproductive Medicine
  • Women's Health
  • Sexual Health

Background:

  • Female sexual dysfunction (FSD) is now understood to have multiple organic etiologies, shifting from previous beliefs of it being primarily psychological.
  • FSD is a complex of symptoms involving physiological changes that can be addressed through treating underlying conditions or supportive care.

Purpose of the Study:

  • To detail the clinical evaluation and physical examination process for women presenting with FSD.
  • To outline current research and treatment options for female sexual dysfunction.

Main Methods:

  • Review of recent diagnostic classifications for FSD.
  • Incorporation of validated FSD questionnaires for treatment efficacy monitoring.
  • Clinical evaluation and physical examination protocols for FSD assessment.

Related Experiment Videos

Main Results:

  • A new diagnostic classification enables physicians to clinically evaluate women with FSD.
  • Validated questionnaires provide a means to monitor the effectiveness of FSD treatments.
  • Established protocols for clinical evaluation and physical examination are crucial for FSD management.

Conclusions:

  • FSD is rooted in organic causes, necessitating a comprehensive clinical approach.
  • Physicians can now better evaluate and manage FSD using new classifications and validated tools.
  • Ongoing research and evolving treatment options offer improved prospects for women with FSD.